Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

La resistencia a los antibióticos en Tanzania es un problema ambiental

Investigadores de la Universidad Estatal de…

Engineered bacteria could help protect ‘good’ gut microbes from antibiotics

Engineered bacteria could help protect ‘good’…

Assumptions of how antibiotics work may be incorrect

Bacterial infections are the No. 1 cause of…

Burnout laboral: 75% de los mexicanos lo padece

Si te has sentido desmotivado, apático e…

How India’s hospitals, rivers and chickens are driving global antibiotic resistance

A 59-year-old man from India, who was living in…

Depresión: un trastorno que afecta al 4% de la población mundial

La depresión está catalogada por la Organización…

How plankton hold secrets to preventing pandemics

A team of researchers led by postdoctoral…